Smart software aims to simplify HIV treatment decisions
NCT ID NCT07219862
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a software tool called smART that helps doctors pick the best combination of HIV drugs for each patient. The tool considers drug resistance, other health conditions, and medication safety. Researchers will compare treatment choices made with and without the tool using 250 patient cases. The goal is to see if the tool helps doctors follow guidelines more closely and make decisions faster.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- smART (Smart Antiretroviral Therapy Assistant) software tool
- What this could lead to
- If successful, this tool could help general doctors make faster, more accurate HIV treatment decisions, potentially improving patient outcomes.
- What could go wrong
- This is a small, early-stage study using simulated patient cases, not real-world treatment. The tool may not improve outcomes or be adopted in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Los Angeles General Medical Center
Los Angeles, California, 90033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cash for care: a simple incentive to keep HIV patients on track
- Olive oil as a shield? trial tests whether a daily spoonful cuts heart risks in HIV
- Are clinics missing advanced HIV cases? a new study investigates
- Specialized HIV clinics: a new strategy to beat the virus?
- A mobile x-ray van with AI could spot TB before it spreads
- A simple survey may curb teen drinking and HIV risk — a trial puts it to the test